glutathione mutations in sclc patients Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation | Cancer & Metabolism Small cells – big issues:
Small cells big issues: biological implications and preclinical advancements in small cell lung cancer Molecular Cancer Springer Nature Link Frontiers Therapeutic Potential of Glutamine Pathway in Lung Cancer Frontiers Metabolic reprogramming in lung cancer and its clinical implication Increased antioxidative defense and reduced advanced glycation end product formation by metabolic adaptation in non small cell lung cancer patients Nature Communications
Pay in 4 interest-free payments of $6.87 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



